Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid

Scanning Microscopy

Volumn 10, Issue 2, 1996, Pages 415-424

  Wesson, Jeffrey A ^a,b   Worcester, Elaine ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Calcium oxalate; Crystal inhibitors; Crystal morphology; Crystallization; Nephrolithiasis; Polyaspartic acid

Indexed keywords

CALCIUM OXALATE; POLYASPARTIC ACID;

AQUEOUS SOLUTION; ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; HUMAN; HUMAN CELL; MICTURITION; NEPHROLITHIASIS; PARTICLE SIZE; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; SOLUBILIZATION; X RAY DIFFRACTION;

CALCIUM OXALATE; CRYSTALLIZATION; HUMANS; KIDNEY CALCULI; PEPTIDES;

EID: 0030316701     PISSN: 08917035     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Addadi L, Weiner S (1985) Interactions between acidic proteins and crystals: Stereochemical requirements in biomineralization. Proc Natl Acad Sci 82: 4110-4114.
2. Bunker BC, Rieke PC, Tarasevich BJ, Campbell AA, Fryxell GE, Graff GL, Song L, Liu J, Virden JW, McVay GL (1994) Ceramic thin-film formation on functionalized interfaces through biomimetic processing. Science 264: 48-55.
3. Butler WT (1989) The nature and significance of osteopontin. Connect Tissue Res 23: 123-136.
4. Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. New Engl J Med 327: 1141-1152.
5. Denhardt DT, Guo X (1993) Osteopontin: A protein with diverse functions. FASEB J 7: 1475-1482.
6. Elliot JS, Rabinowitz IN (1980) Calcium oxalate crystalluria: Crystal size in urine. J Urol 123: 324-327.
7. Fellstrom B, Danielson BG, Ljunghall S, Wikstrom B (1986) Crystal inhibition: The effects of polyanions on calcium oxalate crystal growth. Clin chim Acta 158: 229-235.
8. Fleisch H (1978) Inhibitors and promoters of stone formation. Kidney Int 13: 361-371.
9. Furedi-Milhofer H, Tunik L, Bloch R, Garti N (1994) The influence of surfactants on the crystallization of calcium oxalate hydrates. Mol Cryst Liq Cryst 248: 199-206.
10. Grover PK, Ryall RL, Marshall VR (1990) Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine? Clin chim Acta 190: 223-238.
11. Ito H, Coe FL (1977) Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. Am J Physiol 233: F455-F463.
12. Mandel N (1994) Crystal-membrane interaction in kidney stone disease. J Am Soc Nephrol 5: S37-S45.
13. Mandel NS, Mandel GS (1989) Urinary tract stone disease in the United States veteran population. I. Geographical frequency of occurrence. J Urol 142: 1513-1515.
14. Mandel NS, Mandel GS (1989) Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol 142: 1516-1521.
15. Mandel N, Riese R (1991) Crystal-cell interactions: Crystal binding to rat renal papillary tip collecting duct cells in culture. Am J Kidney Dis 17: 402-406.
16. Martin X, Smith LH, Weraess PG (1984) Calcium oxalate dihydrate formation in urine. Kidney Int 25: 948-952.
17. Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MAS (1994) Clinical and biochemical differ- ences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151: 571-574.
18. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein super-family. Proc Natl Acad Sci 89: 426-430.
19. Tomazic BB, Nancollas GH (1979) A study of the phase transformation of calcium oxalate trihydrate-monohydrate. Invest Urol 16: 329-335.
20. Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL2: A BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242-1244.
21. Wiessner JH, Mandel GS, Mandel NS (1986) Membrane interactions with calcium oxalate crystals: Variation in hemolytic potentials with crystal morphology. J Urol 135: 835-839.
22. Wiessner JH, Kleinman JG, Blumenthal SS, Garansic JC, Mandel GS, Mandel NS (1987) Calcium oxalate crystal interaction with rat renal inner papillary collecting tubule cells. J Urol 138: 640-643.
23. Worcester EM, Beshensky AM (1995) Osteopontin inhibits nucleation of calcium oxalate crystals. Ann NY Acad Sci 760: 375-377.
24. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL (1992) The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7: 1029-1036.